Hot topics

Boostrix now recommended from 16 weeks of every pregnancy

From 1 July 2019, Boostrix® (Tdap) is funded from the second trimester of every pregnancy and recommended to be administered from 16 weeks. For best protection of the newborn the booster immunisation is recommended to be administered from 16 weeks of pregnancy, preferably within the second trimester, but at least two weeks prior to birth to:

Click to read more

Influenza vaccine supply issue

UPDATE Additional influenza vaccine stock 6 July 2019 The Ministry of Health and PHARMAC have advised that an additional 55,000 doses of the influenza vaccine FluQuadri have been sourced for delivery to New Zealand from Monday 8 July. This should enable providers to receive delivery from later that week onwards. Providers can now place orders for FluQuadri through HCL. A minimum and maximum order of 30 doses applies. FluQuadri is supplied with separate needles.

Click to read more

Measles overseas and in New Zealand

Born 1969 or later? Ensure you are protected from measles. Since 2012, all cases of measles in New Zealand came from travellers bringing the disease from overseas. There are currently significant measles outbreaks overseas and outbreaks in New Zealand.

Click to read more

Boostrix single pack going needle-free

GSK has advised that the single dose pack for Boostrix (Tdap) supplied for use as part of the National Immunisation Schedule will transition to a needle-free pack from June 2019. Only the needle has been removed from the pack. The manufacturing site, vaccine formulation, and components of Boostrix remain unchanged.

Click to read more

Infant deaths in Samoa a tragic outcome from error preparing MMR vaccine

The deaths of two infants on 6 July 2018 in Samoa shortly after receiving their MMR immunisations were under investigation by the Samoan Ministry of Health and Samoan Police. However, the inquest was put on hold until the trial of the two nurses who administered the MMR vaccines had been completed.

Click to read more

April 2019 - UPDATE on HBvaxPRO 10mcg and HBvaxPRO 40mcg stock

HBvaxPRO® 5 mcg strength vaccine Stock of the paediatric HBvaxPRO 5mcg/0.5mL vaccine for neonates and children is available at all ProPharma branches. Please ensure you note the change in dose and volume. Engerix-B 20mcg/1mL continues to be the hepatitis B vaccine available for adolescents aged 11–15 years following the two-dose schedule, with the second dose given 4–6 months after the first, and adults aged 20 years or older. HBvaxPRO® 10 mcg strength vaccine is out of stock

Click to read more

WHO publishes the 2018 Assessment Report of the Global Vaccine Action Plan

The WHO Strategic Advisory Group of Experts (SAGE) on immunization have released the 2018 Assessment Report of the Global Vaccine Action Plan.

Click to read more

Answers to frequent concerns and questions arising from Vaxxed

Vaxxed is a film directed by Andrew Wakefield, the former British gastroenterologist who published fraudulent research that claimed the MMR vaccine caused autism. The film is based on claims that unfavourable safety data on the MMR vaccine was covered up by the United States Centers for Disease Control and Prevention. The content of the film has been widely discredited by the global medical and scientific communities.

Click to read more

Last updated: May 2017